# Scilex Holding Company (SCLX)

> Source: Nexqual · https://nexqual.com/SCLX · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Scilex Holding Company (SCLX), nexqual.com/SCLX" · informational, not investment advice.

**Price:** USD 2.82 (-1.05% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.85 · day 2.77–2.85 · 52w 2.62–16.81 · market cap $19.8M · NCM

## Key facts
- Total return with dividends: 1Y -66.0% vs S&P 500 +18.1%; 5Y -98.7% vs S&P 500 +85.1%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -66.0% | -98.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -66.1% | -58.0% |
| Volatility (annualized) | 99.5% | 114.3% |
| Max drawdown | -80.0% (Nov 2025→Oct 2026) | -99.2% (Apr 2023→May 2025) |

## Peers (Drug Manufacturers - General)
OGN (Organon & Co.) USD 13.76 -0.07% · GRFS (Grifols, S.A.) USD 7.54 +5.16% · BIIB (Biogen Inc.) USD 235.35 +2.82% · SNY (Sanofi) USD 40.29 +2.99% · GSK (GSK plc) USD 49.02 +5.94% · BMY (Bristol-Myers Squibb Company) USD 60.57 +6.88%

## More
Full page: https://nexqual.com/SCLX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt